These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2977119)

  • 1. Therapeutic choices for rheumatic disorders.
    Hughes G
    Gerontology; 1988; 34 Suppl 1():27-32. PubMed ID: 2977119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states.
    Balfour JA; Buckley MM
    Drugs; 1991 Aug; 42(2):274-99. PubMed ID: 1717225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the antiarthritic efficacy and safety of etodolac.
    Zvaifler N
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():43-53. PubMed ID: 2525982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Special considerations in the use of NSAIDs in the elderly.
    Todesco S
    Eur J Rheumatol Inflamm; 1994; 14(1):7-13. PubMed ID: 7744127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selection of a nonsteroidal antiinflammatory drug. Is there a difference?
    Willkens RF
    J Rheumatol Suppl; 1992 Nov; 36():9-12. PubMed ID: 1474545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An updated safety profile of etodolac in several thousand patients.
    Schattenkirchner M
    Eur J Rheumatol Inflamm; 1990; 10(1):56-65. PubMed ID: 2146132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee.
    Perpignano G; Bogliolo A; Puccetti L
    Int J Clin Pharmacol Res; 1994; 14(5-6):203-16. PubMed ID: 7672877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of etodolac in subjects with renal impairment.
    Brater DC
    Eur J Rheumatol Inflamm; 1990; 10(1):44-55. PubMed ID: 2146131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drug toxicity: increased risk in the elderly.
    Weinblatt ME
    Scand J Rheumatol Suppl; 1991; 91():9-17. PubMed ID: 1771396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions and toxic effects of the nonsteroidal anti-inflammatory drugs.
    Simon LS
    Curr Opin Rheumatol; 1994 May; 6(3):238-51. PubMed ID: 8060759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach.
    Davies NM; Skjodt NM
    Clin Pharmacokinet; 2000 May; 38(5):377-92. PubMed ID: 10843458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merits and liabilities of NSAID therapy.
    Roth SH
    Rheum Dis Clin North Am; 1989 Aug; 15(3):479-98. PubMed ID: 2672133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effectiveness and safety of etodolac in prolonged treatment of active osteoarthritis.
    Puccetti L; Ciompi ML
    Int J Clin Pharmacol Res; 1991; 11(3):143-58. PubMed ID: 1839736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction and selection of therapeutic agents in the elderly: NSAIDs and the ageing kidney.
    Stillman MT
    Scand J Rheumatol Suppl; 1989; 82():33-8. PubMed ID: 2638520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroscopic evaluation of the effects of nabumetone on the gastrointestinal mucosa of rheumatic patients.
    Bianchi Porro G; Petrillo M; Ardizzone S; Caruso I; Montone F
    Eur J Rheumatol Inflamm; 1991; 11(3):38-42. PubMed ID: 1365479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical response to etodolac in the management of pain.
    Mizraji M
    Eur J Rheumatol Inflamm; 1990; 10(1):35-43. PubMed ID: 1699764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale open trials with etodolac (Lodine) in France: an assessment of safety.
    Benhamou CL
    Rheumatol Int; 1990; 10 Suppl():29-34. PubMed ID: 2150569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the risk-benefit ratio of NSAID therapy in the elderly.
    Hodinka L
    Scand J Rheumatol Suppl; 1991; 91():3-8. PubMed ID: 1771394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal anti-inflammatory drugs. Differential use in older patients.
    Girgis L; Brooks P
    Drugs Aging; 1994 Feb; 4(2):101-12. PubMed ID: 8186538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etodolac and the treatment of arthritis.
    Scott DL
    Eur J Rheumatol Inflamm; 1990; 10(1):1-2. PubMed ID: 2146128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.